The assessment of glucocorticoid replacement therapy

[1] EFFECT OF GLUCOCORTICOID REPLACEMENT THERAPY ON GLUCOSE-TOLERANCE AND INTERMEDIARY METABOLITES IN HYPOPITUITARY ADULTS [J]. CLINICAL ENDOCRINOLOGY, 1995, 42 (01) : 85 - 90

[2] ENDOCRINE AND METABOLIC DISEASES - ADRENAL DISEASES [J]. BRITISH MEDICAL JOURNAL, 1976, 1 (6007) : 448 - 451

[3] DAILY CORTISOL PRODUCTION-RATE IN MAN DETERMINED BY STABLE ISOTOPE-DILUTION MASS-SPECTROMETRY [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) : 39 - 45

[4] PATTERNS OF PLASMA-CORTISOL AND ACTH CONCENTRATIONS IN PATIENTS WITH ADDISONS-DISEASE TREATED WITH CONVENTIONAL CORTICOSTEROID REPLACEMENT [J]. CLINICAL ENDOCRINOLOGY, 1981, 14 (05) : 451 - 458

[5] CORTICOSTEROID REPLACEMENT THERAPY - TWICE OR THRICE DAILY [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1988, 81 (09) : 514 - 516

[6] HOWLETT TA, 1997, CLIN ENDOCRINOLOGY, V46

[7] PEACEY SR, 1997, CLIN ENDOCRINOLOGY, V46

[8] Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (01) : 33 - 37

[9] THE EFFECT OF GROWTH-HORMONE REPLACEMENT ON CORTISOL METABOLISM AND GLUCOCORTICOID SENSITIVITY IN HYPOPITUITARY ADULTS [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (05) : 639 - 648

[10] THE EFFECT OF LOW-DOSE RECOMBINANT HUMAN GROWTH-HORMONE REPLACEMENT ON REGIONAL FAT DISTRIBUTION, INSULIN SENSITIVITY, AND CARDIOVASCULAR RISK-FACTORS IN HYPOPITUITARY ADULTS [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) : 153 - 159

[1] EFFECT OF GLUCOCORTICOID REPLACEMENT THERAPY ON GLUCOSE-TOLERANCE AND INTERMEDIARY METABOLITES IN HYPOPITUITARY ADULTS [J]. CLINICAL ENDOCRINOLOGY, 1995, 42 (01) : 85 - 90

[2] ENDOCRINE AND METABOLIC DISEASES - ADRENAL DISEASES [J]. BRITISH MEDICAL JOURNAL, 1976, 1 (6007) : 448 - 451

[3] DAILY CORTISOL PRODUCTION-RATE IN MAN DETERMINED BY STABLE ISOTOPE-DILUTION MASS-SPECTROMETRY [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (01) : 39 - 45

[4] PATTERNS OF PLASMA-CORTISOL AND ACTH CONCENTRATIONS IN PATIENTS WITH ADDISONS-DISEASE TREATED WITH CONVENTIONAL CORTICOSTEROID REPLACEMENT [J]. CLINICAL ENDOCRINOLOGY, 1981, 14 (05) : 451 - 458

[5] CORTICOSTEROID REPLACEMENT THERAPY - TWICE OR THRICE DAILY [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1988, 81 (09) : 514 - 516

[6] HOWLETT TA, 1997, CLIN ENDOCRINOLOGY, V46

[7] PEACEY SR, 1997, CLIN ENDOCRINOLOGY, V46

[8] Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy [J]. CLINICAL ENDOCRINOLOGY, 1996, 45 (01) : 33 - 37

[9] THE EFFECT OF GROWTH-HORMONE REPLACEMENT ON CORTISOL METABOLISM AND GLUCOCORTICOID SENSITIVITY IN HYPOPITUITARY ADULTS [J]. CLINICAL ENDOCRINOLOGY, 1994, 41 (05) : 639 - 648

[10] THE EFFECT OF LOW-DOSE RECOMBINANT HUMAN GROWTH-HORMONE REPLACEMENT ON REGIONAL FAT DISTRIBUTION, INSULIN SENSITIVITY, AND CARDIOVASCULAR RISK-FACTORS IN HYPOPITUITARY ADULTS [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) : 153 - 159